期刊文献+

ICU内中心静脉导管相关性血流感染病原菌耐药性分析

ICU Central Venous Catheter Related Bloodstream Infections Pathogens Resistance Analysis
暂未订购
导出
摘要 目的:了解ICU内中心静脉导管相关性血流感染(CRBSI)病原菌的分布特点及其耐药性,以指导临床合理用药。方法:回顾性分析2009年1月至2011年12月ICU内CRBSI患者病原菌分布和药物敏感试验资料,比较排位前7位细菌的耐药特征。结果:67例CRBSI患者共检出81株病原菌,其中革兰阳性(G')菌40株,占49.2%;革兰阴性(G^-)菌38株,占46.9%;真菌3株,占3.7%,引起CRBSI的主要病原菌依次为凝固菌阴性葡萄球菌(27株,33.3%),鲍曼不动杆菌(12株,14.8%),肺炎克雷伯菌(9株,11.1%),金黄色葡萄球菌(8株,9.9%),铜绿假单胞菌(7株,8.6%),大肠埃希菌(6株,7.4%),G^+菌中对碳青霉烯菌类最为敏感。结论:近3年来ICU内CRBSI患者病原菌以表皮葡萄球菌及鲍曼不动杆菌为主,并且鲍曼不动杆菌耐药率较高。 Objective: To learn the features and drug resistance of pathogens in ICU central venous catheter related bloodstream infections (CRBSI) and to guide rational drug use. Methods: Through retrospective analysis of clinical data of pathogenic bacteria distribution and drug sensitive in ICU CRBSI patients from January, 2009 to December, 20 11, to compare the drug resistance of the former 7 strains of bacteria. Results: There are totally 81 strains of pathogens, among which 40 strains of Gram-positive bacteria (G+), accounting for 49.2%; 38 Gram-negative bacteria (G) with 46.9%; 3 fungi is 3.7%. The main pathogenic bacteria that cause CRBSI are coagulase negative staphylococcus (27 strains, 33.3%), Acinetobacter baumanii (12 strains, 14.8%), pneumonia gram Reber fungus (9 trains, 11.1%), Staphylococcus aureus (8 stains, 9.9%), Pseudomonas aeruginosa (7 strains, 8.6%), E. coli (6 strains, 7.4%). G^+ bacteria were mainly of Staphylococcus epidermidis, while G bacteria were mainly of Acinetobacter baumanii. The resistance rate to vancomycin of G+ bacteria was 0, and G^- bacteria was most sensitive to carbapenemases. Conclusion: In recent three years, the pathogens of ICU CRBSI patients were mainly of Staphylococcus epidermidis and Acinetobacter baumanii, and Acinetobacter baumanii were of high drug resistance.
出处 《麻醉与监护论坛》 2012年第6期452-454,共3页 Forum of Anesthesia and Monitoring
关键词 相关性感染 血培养 细菌耐药 重症加强治疗病房 Related infection Blood cultures Antibiotic resistance Intensive care unit (ICU)
  • 相关文献

参考文献12

  • 1Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis, 2009, 49:1-45.
  • 2Fluit AC. Schmitt FJ. VerhoefJ. et al. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia.skin and soft tissue, and urinary tract infections occurring in European patients. Eur J Clin Microbiol Infect Dis,2001. 20:188-191.
  • 3Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med. 1999,20:303-316.
  • 4DimickJB. Pelz RK. Consunji R. et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg, 2001. 136:229-234.
  • 5黄伟,罗运山,周俊峰,张久之,万献尧.ICU内中心静脉导管相关性血行性感染患者的预后危险因素与住院费用分析[J].中国呼吸与危重监护杂志,2010,9(3):239-242. 被引量:21
  • 6Liu C. Bayer A. Cosgrove SE, et al, Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphyloceccus aureus infections in adults and children: executive summary. Clin Infect Dis, 2011, 52: 285-292.
  • 7Moubareck C, Meziane-Cherif D, Courvalin P, et al. VanA-type Staphylococcus aueens strain VRSA-7 is partially dependent on vancomycin for growth. Antimicrob Agenes Chemother, 2009, 53:3657-3663.
  • 8Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis. 2008. 8:751-762.
  • 9Grik K. Dierich MP. Pfaller K. et al. In vitro activity of fosfomyein in combination with various antist phylococcal substances.J Antimicrob Chemother, 2001, 48:209-2171.
  • 10李骏,万献尧.血管内导管相关性血流感染诊治进展[J].中国呼吸与危重监护杂志,2012,11(4):410-414. 被引量:24

二级参考文献14

  • 1刘大鹰,谢正福,施焕中,覃雪军,陈强,肖常青.重症监护病房与非重症监护病房中心静脉导管相关感染的对比研究[J].中国呼吸与危重监护杂志,2006,5(3):162-167. 被引量:45
  • 2Valles J, Ferrer R. Bloodstream infection in the ICU. Infect Dis Clin North Am ,2009,23:557-569.
  • 3Digiovine B, Chenoweth C, Watts C, et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med, 1999,160:976- 981.
  • 4Warren DK, Quadir WW, Hollenbeak CS, et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med,2006,34:2084- 2089.
  • 5Renaud B, Brun-Buisson C, ICU-Bacteremia Study Group. Outcomes of primary and catheter-related bacteremia. A cohort and casecontrol study in critically ill patients. Am J Respir Crit Care Med, 2001,163 : 1584-1590.
  • 6Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control, 2008,36:309-332.
  • 7Suljagic V, Cobeljic M, Jankovic S, et al. Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control,2005, 33:333-340.
  • 8Harbarth S, Ferriere K, Hugonnet S, et al. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg, 2002,137 : 1353-1359.
  • 9Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 2001,344 : 699 -709.
  • 10Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia:a prospective study of patients not initially admitted to the ICU. Chest,2005,127:1260-1270.

共引文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部